PREVIOTOX

Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs for medical purposes and also including collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes; DNA collection kit comprised of DNA collection laboratory swab and swab handle for medical purposes

Anatomic pathology specimen collection kits for use in genetic testing comprised primarily of saliva and blood collection containers for medical purposes sold empty, printed instructions, printed shipping labels and transport packaging; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes

Scientific research services, namely, DNA screening and genetic testing; medical research services, namely, DNA screening and genetic testing; Medical laboratory testing services; medical and scientific research in the field of genetics and DNA analysis; scientific research and development services relating to predicting toxicity in connection with immunotherapy treatments; research and development for the purpose of determining treatment selection in the field of immune oncology; providing scientific and medical research information in the field of genetics and DNA analysis

Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with immunotherapy treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with immunotherapy treatments